| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Treu Jesse I is a Director at ALDX, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 15 sales. Those positions are worth an estimated $43.7M at current prices.
Treu Jesse I's largest disclosed position is in VCYT as Director, worth about $24.9M. The recent filings there lean toward selling, a net 1,554,377 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2019 | ALDX Aldeyra Therapeutics, Inc. | Director | Sell | 96,743 | $10.01 | $968,397.43 | -91.7% | |
| Mar 4, 2019 | VCYT Veracyte, Inc. | Director | Sell | 1,052,151 | $20.37 | $21,432,871.71 | -100% | |
| Aug 1, 2018 | VCYT Veracyte, Inc. | Director | Sell | 500,000 | $10.83 | $5,413,600.00 | -96.7% | |
| May 16, 2017 | VCYT Veracyte, Inc. | Director | Sell | 2,226 | $8.08 | $17,986.08 | -9.8% |